The trademark application ForeSENTIA was filed by MEDICOVER PUBLIC CO LTD, a corporation established under the laws of the Republic of Cyprus (the "Applicant"). The application was published for oppositions on February 18, 2020, and it was registered by office on May 28, 2020 without any oppositions.
It was designated 'Basic Application' for International Application 1543046 at the World Intellectual Property Organization (WIPO).
The application was filed in English (Spanish was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on October 6, 2022. Change of name and address of the trademark registration was recorded on November 10, 2022. Appointment and Replacement of representative of the trademark registration was recorded on November 16, 2023.
Goods And Services
The mark was filed in class 1 with following description of goods:
Kits and reagents for genetic testing for medical and scientific research purposes in the field of oncology
Kits and reagents for cancer testing for medical and scientific research purposes
Nucleic acid-based kits and reagents for testing cancer diseases for medical and scientific research purposes.
The mark was filed in class 42 with following description of goods:
Medical laboratory services for cancer genetic tests
Medical laboratory services for identifying genetic mutations in cancer development
Design and development of medical diagnostic tests and products
Medical and scientific research in the field of genetic testing
Providing medical and scientific research information in the field of genetic testing
Genetic testing for scientific research and analysis purposes in the field of cancer genetics
Genetic engineering services
Scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of nucleic acid analysis, cancer testing, and genetics
Scientific research for medical purposes in the area of cancerous diseases.
The mark was filed in class 44 with following description of goods:
Medical analysis services for the diagnosis and prognosis of cancer
Medical genetic testing services for diagnosis, prevention and treatment of cancer
Medical testing of tumour biological samples for diagnosis of cancer
Genetic testing and genetic counseling in the field of cancer detection
Medical and health services relating to DNA and genetics testing
RNA or DNA analysis for cancer diagnosis and prognosis.